Our Approach to Clinical Development
Our clinical development approach focuses on matching our drug mechanism to patient biology and using relevant outcome metrics that keep patient benefit a top priority.
Match MOA to patient biology
The mechanism of action of our drug should match the underlying biology of the patient population we aim to treat.
Use relevant metrics
Clinical trial outcomes should directly measure the expected benefits of our drug on patients.
Progressive but anchored trial design
Our clinical trial design should utilize modern, progressive techniques but remain anchored to outcomes that matter to patients.
Focus on patient benefit
We prioritize what is best for patients in our clinical development approach.